TELA - TELA Bio, Inc.
0.78
-0.020 -2.526%
Share volume: 90,870
Last Updated: 04-28-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.80
-0.02
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-08-2024 | 03-21-2025 | 05-08-2025 | 11-14-2025 | 03-25-2026 | |
| Assets | ||||||||
| Total Assets | 71.837 M | 60.204 M | 53.016 M | 86.570 M | 77.251 M | 61.587 M | 81.418 M | |
| Current Assets | 62.618 M | 51.109 M | 44.132 M | 78.071 M | 69.745 M | 56.048 M | 75.581 M | |
| Inventories | 13.602 M | 13.372 M | 13.600 M | 12.781 M | 13.533 M | 11.558 M | 11.016 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 37.143 M | 26.496 M | 17.301 M | 52.670 M | 42.833 M | 29.713 M | 50.845 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.325 M | 2.349 M | 2.423 M | 2.341 M | 2.201 M | 2.213 M | 2.226 M | |
| Other Assets | 6.894 M | 6.746 M | 6.461 M | 6.158 M | 5.305 M | 3.326 M | 3.611 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 71.837 M | 60.204 M | 53.016 M | 86.570 M | 77.251 M | 61.587 M | 81.418 M | |
| Total liabilities | 57.453 M | 57.334 M | 59.288 M | 58.112 M | 59.128 M | 60.030 M | 75.105 M | |
| Total current liabilities | 15.179 M | 14.989 M | 16.858 M | 15.598 M | 16.536 M | 16.977 M | 17.975 M | |
| Accounts Payable | 3.357 M | 2.314 M | 2.479 M | 2.147 M | 4.002 M | 2.373 M | 2.309 M | |
| Other liabilities | 1.609 M | 1.528 M | 1.460 M | 1.390 M | 1.317 M | 1.559 M | 1.477 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 40.665 M | 40.817 M | 40.970 M | 41.124 M | 41.275 M | 41.494 M | 55.653 M | |
| Other liabilities | 1.609 M | 1.528 M | 1.460 M | 1.390 M | 1.317 M | 1.559 M | 1.477 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 14.384 M | 2.870 M | -6.272 M | 28.458 M | 18.123 M | 1.557 M | 6.313 M | |
| Common stock | 340.837 M | 341.922 M | 343.101 M | 387.098 M | 388.026 M | 389.986 M | 403.783 M | |
| Retained earnings | -326.550 M | -339.150 M | -349.522 M | -358.730 M | -369.994 M | -388.520 M | -397.561 M |